About
MediBeacon develops fluorescent tracer agents and transdermal detection technology to noninvasively measure and monitor physiological functions such as kidney function via Glomerular Filtration Rate (GFR) assessment for clinical and preclinical applications.
Explore MediBeacon's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.